Picture of Pixium Vision SA logo

ALPIX — Pixium Vision SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Pixium Vision: Positive Follow-Up Data From French Trial Of Prima System

March 31 (Reuters) - Pixium Vision SA  ALPIX.PA 
    * ANNOUNCES POSITIVE FOLLOW-UP DATA FROM FRENCH FEASIBILITY
TRIAL
OF PRIMA SYSTEM IN PATIENTS WITH DRY AGE-RELATED MACULAR
DEGENERATION (AMD)

Source text for Eikon:  ID:nGNE2KP7cf 
Further company coverage:  PIX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Pixium Vision SA

See all news